pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 396 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Preclinical
AQ-002
Asthma
Aquilon Pharmaceuticals SA
0 catalysts
Preclinical
AQ-003
Chronic Obstructive Pulmonary Disease (COPD)
Aquilon Pharmaceuticals SA
0 catalysts
Preclinical
ARBM-201
Acute Respiratory Distress Syndrome
Arbormed Co Ltd
0 catalysts
Phase 2
ARCT-032
Cystic Fibrosis
Arcturus Therapeutics Holdings Inc.
← prev
page 5 of 14
next →
131
Pain89
Neurology1
$ARCT
0 catalysts
Preclinical
ATLX–0199
Unspecified Cardiovascular Disorders
Atelerix Life Sciences Inc
0 catalysts
Phase 2
AV-0328
Streptococcal Pneumonia
Alopexx Inc
0 catalysts
Preclinical
AVG-002
Unspecified Respiratory Disorders
AlveoGene Ltd
0 catalysts
Phase 2
AZD-0292
Bronchiectasis
$AZNASTRAZENECA PLC
0 catalysts
Phase 1
AZD-8965
Idiopathic Pulmonary Fibrosis
$AZNASTRAZENECA PLC
0 catalysts
Preclinical
Anti-PD1 Antibody
Lymphangioleiomyomatosis
BioSputnik LLC
0 catalysts
Preclinical
Antibody Drug Conjugate for Idiopathic Pulmonary Fibrosis
Idiopathic Pulmonary Fibrosis
Bionevix Ltd
0 catalysts
Marketed
Augmentin
Augmentin ((amoxicillin + clavulanate potassium))
Skin And Skin Structure Infections (SSSI) Caused By Bacteria
NeoPharma Inc
0 catalysts
Phase 2
BBT-877
Idiopathic Pulmonary Fibrosis
Parataxis Korea Inc
0 catalysts
Phase 2
BI-1819479
Idiopathic Pulmonary Fibrosis
Boehringer Ingelheim International GmbH
0 catalysts
Phase 1
BRS-101
Idiopathic Pulmonary Fibrosis
BreStem Therapeutics Inc
0 catalysts
Phase 1
BSI-502
Atopic Dermatitis (Atopic Eczema)
$ACRSAclaris Therapeutics, Inc.
0 catalysts
Marketed
Bicillin L A
Bicillin L A (penicillin G benzathine)
Upper Respiratory Tract Infections by Streptococcus pyogenes
$PFEPFIZER INC
0 catalysts
Phase 2
Broncho-Vaxom
Wheezing
OM Pharma Ltd
0 catalysts
Preclinical
C-867
Asthma
Raesedo Inc
0 catalysts
Preclinical
C-892
Asthma
Raesedo Inc
0 catalysts
Phase 2
CAL-02
Community-Acquired Bacterial Pneumonia
Eagle Pharmaceuticals Inc
0 catalysts
Phase 2
CAL-101
Idiopathic Pulmonary Fibrosis
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform
Calluna Pharma AS
0 catalysts
Preclinical
CBM-301
Idiopathic Pulmonary Fibrosis
CellionBioMed Inc
0 catalysts
Preclinical
CEN-501
Allergic Rhinitis
NeuCen BioMed Co Ltd
0 catalysts
Phase 2
CHF-6333
Bronchiectasis
Chiesi Farmaceutici SpA
0 catalysts
Phase 1
CHF-6795
Chronic Cough
Chiesi Farmaceutici SpA
0 catalysts
Preclinical
CIL-05
Primary Ciliary Dyskinesia
Cila Therapeutics Inc
0 catalysts
Phase 2
CMTX-101
Pseudomonas aeruginosa Infections
Clarametyx Biosciences Inc
0 catalysts
Preclinical
CTX-002
Coronavirus Disease 2019 (COVID-19) Associated Acute Respiratory Distress Syn…
Ceria Therapeutics Inc
0 catalysts
Phase 2
CX-1739
Central Sleep Apnea
Glutamate receptor ionotropic AMPA
EndeavourRx LLC
0 catalysts